S&P 500

Moderna (MRNA) — 10-Year DCF Projection Model

Free stock research tool. Build a 10-year revenue, earnings (EPS), and free cash flow forecast for Moderna (MRNA) stock, a company in the Health Care (Biotechnology) sector. Pulls audited SEC EDGAR XBRL financials, triangulates Wall Street analyst consensus across Yahoo Finance, NASDAQ, and StockAnalysis, and overlays AI-clustered news + social event probabilities directly onto projected EPS. For equity research — not personal budgeting or accounting.

Build MRNA projection model →Browse all stocks

Moderna at a glance

Ticker
MRNA
Company
Moderna
Sector
Health Care
Sub-industry
Biotechnology
Headquarters
Cambridge, Massachusetts
Founded
2010
Added to S&P 500
2021-07-21
Index membership
S&P 500

What you'll see in your MRNA model

  • 10 years of audited historical financials for Moderna, sourced directly from the SEC's EDGAR XBRL filings (10-K and 10-Q).
  • Triangulated Wall Street consensus for MRNA's forward revenue, EBITDA, and EPS across Yahoo Finance, NASDAQ, and StockAnalysis with cross-source dispersion (σ).
  • AI Event Factors: top-10 news/social themes for MRNA with probability sliders and live EPS impact.
  • Sensitivity tables and Excel export for every assumption.

About Moderna

Moderna (NYSE/NASDAQ: MRNA) was founded in 2010 and is headquartered in Cambridge, Massachusetts. The company operates in the Health Care sector (Biotechnology sub-industry) and is a constituent of the S&P 500. Our projection model builds a clean discounted-cash-flow view of Moderna in roughly five seconds and lets you adjust every assumption to test your own thesis.